Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies

被引:70
作者
Hashimoto, M
Masliah, E
机构
[1] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
关键词
aberrant sprouting; synapse loss; Alzheimer's disease; Lewy bodies; APP; alpha-synuclein;
D O I
10.1023/A:1026073324672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are the most common neurodegenerative disorders affecting the elderly. The cognitive and motor deficits in these diseases are associated with the disruption of neuritic substructure, loss of synaptic contacts in selectively vulnerable circuitries, and aberrant sprouting. Where as in AD, accumulation of misfolded forms of Abeta triggers neurodegeneration, in DLB accumulation of alpha-synuclein might play a central role. The mechanisms by which oligomeric forms of these proteins might lead to cycles of synapse loss and aberrant sprouting are currently under investigation. Several possibilities are being considered, including mitochondrial damage, caspase activation, lysosomal leakage, fragmentation of the Golgi apparatus, interference with synaptic vesicle transport and function, and interference with gene transcription and signaling. Among them, recent lines of research support the possibility that alterations in signaling pathways such extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 relevant to synaptic plasticity and cell survival might play a pivotal role. A wide range of cellular functions are affected by the accumulation of misfolded Abeta and alpha-synuclein; thus it is possible that a more fundamental cellular alteration may underlie the mechanisms of synaptic pathology in these disorders. Among them, one possibility is that scaffold proteins, such as caveolin and JNK-interacting protein (JIP), which are necessary to integrate signaling pathways, are affected, leading to cycles of synapse loss and aberrant sprouting. This is significant because both caveolar dysfunction and altered axonal plasticity might be universally important in the pathogenesis of various neurodegenerative disorders, and therefore these signaling pathways might be common therapeutic targets for these devastating diseases.
引用
收藏
页码:1743 / 1756
页数:14
相关论文
共 157 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   A-synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells [J].
Ahn, BH ;
Rhim, H ;
Kim, SY ;
Sung, YM ;
Lee, MY ;
Choi, JY ;
Wolozin, B ;
Chang, JS ;
Lee, YH ;
Kwon, TK ;
Chung, KC ;
Yoon, SH ;
Hahn, SJ ;
Kim, MS ;
Jo, YH ;
Min, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :12334-12342
[3]  
ANDERSON B, 1995, MED SCI RES, V23, P597
[4]  
[Anonymous], CEREBRAL CORTEX
[5]   EPITOPE ANALYSIS OF SENILE PLAQUE COMPONENTS IN THE HIPPOCAMPUS OF PATIENTS WITH PARKINSONS-DISEASE [J].
ARAI, H ;
SCHMIDT, ML ;
LEE, VMY ;
HURTIG, HI ;
GREENBERG, BD ;
ADLER, CH ;
TROJANOWSKI, JQ .
NEUROLOGY, 1992, 42 (07) :1315-1322
[6]   NEUROFIBRILLARY TANGLES BUT NOT SENILE PLAQUES PARALLEL DURATION AND SEVERITY OF ALZHEIMERS-DISEASE [J].
ARRIAGADA, PV ;
GROWDON, JH ;
HEDLEYWHYTE, ET ;
HYMAN, BT .
NEUROLOGY, 1992, 42 (03) :631-639
[7]  
BEER J, 1989, SOC NEUR ABSTR, V15, P547
[8]   Deafferentative synaptopathology in physiological aging and Alzheimer's disease [J].
Bertoni-Freddari, C ;
Fattoretti, P ;
Delfino, A ;
Solazzi, M ;
Giorgetti, B ;
Ulrich, J ;
Meier-Ruge, W .
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 :322-326
[9]   Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele [J].
Blennow, K ;
Bogdanovic, N ;
Alafuzoff, I ;
Ekman, R ;
Davidsson, P .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (05) :603-618
[10]  
Bloch-Shilderman E, 2001, J PHARMACOL EXP THER, V296, P704